108 related articles for article (PubMed ID: 12679396)
1. Total-Body Multiparametric PET Quantification of
Wang Y; Nardo L; Spencer BA; Abdelhafez YG; Li EJ; Omidvari N; Chaudhari AJ; Badawi RD; Jones T; Cherry SR; Wang G
J Nucl Med; 2023 Nov; 64(11):1821-1830. PubMed ID: 37591539
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Reproducibility of 18F-Fluciclatide PET Imaging in Subjects with Solid Tumors.
Sharma R; Kallur KG; Ryu JS; Parameswaran RV; Lindman H; Avril N; Gleeson FV; Lee JD; Lee KH; O'Doherty MJ; Groves AM; Miller MP; Somer EJ; Coombes CR; Aboagye EO
J Nucl Med; 2015 Dec; 56(12):1855-61. PubMed ID: 26383153
[TBL] [Abstract][Full Text] [Related]
3. Total-Body Multiparametric PET Quantification of
Wang Y; Nardo L; Spencer BA; Abdelhafez YG; Li EJ; Omidvari N; Chaudhari AJ; Badawi RD; Jones T; Cherry SR; Wang G
medRxiv; 2023 Mar; ():. PubMed ID: 37034643
[TBL] [Abstract][Full Text] [Related]
4. FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements.
Osman MM; Muzaffar R; Altinyay ME; Teymouri C
Front Oncol; 2011; 1():41. PubMed ID: 22655246
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT.
Cheng C; Heiss C; Dimitrakopoulou-Strauss A; Govindarajan P; Schlewitz G; Pan L; Schnettler R; Weber K; Strauss LG
Am J Nucl Med Mol Imaging; 2013; 3(2):118-28. PubMed ID: 23526138
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Immuno-PET of CD138 and PET imaging with
Bailly C; Gouard S; Lacombe M; Remaud-Le Saëc P; Chalopin B; Bourgeois M; Chouin N; Tripier R; Halime Z; Haddad F; Faivre-Chauvet A; Kraeber-Bodéré F; Chérel M; Bodet-Milin C
Oncotarget; 2018 Feb; 9(10):9061-9072. PubMed ID: 29507674
[TBL] [Abstract][Full Text] [Related]
7. Not everything that shines is gold, normal uptake in crista terminalis on FDG PET/CT masquerading as a tumor thrombus approaching right heart.
Ghesani A; Cangut B; Stempler L
Radiol Case Rep; 2024 Feb; 19(2):513-518. PubMed ID: 38044900
[TBL] [Abstract][Full Text] [Related]
8. Impact of Renal Failure on F18-FDG PET/CT Scans.
Kode V; Karsch H; Osman MM; Muzaffar R
Front Oncol; 2017; 7():155. PubMed ID: 28785537
[TBL] [Abstract][Full Text] [Related]
9. Computational modeling of PET tracer distribution in solid tumors integrating microvasculature.
Fasaeiyan N; Soltani M; Moradi Kashkooli F; Taatizadeh E; Rahmim A
BMC Biotechnol; 2021 Nov; 21(1):67. PubMed ID: 34823506
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of ¹¹C-methionine PET/CT in patients with plasma cell malignancy: comparison with ¹⁸F-FDG PET/CT.
Nakamoto Y; Kurihara K; Nishizawa M; Yamashita K; Nakatani K; Kondo T; Takaori-Kondo A; Togashi K
Eur J Nucl Med Mol Imaging; 2013 May; 40(5):708-15. PubMed ID: 23340595
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats.
Aerts JJ; Plenevaux AR; Lemaire CF; Giacomelli F; Warnock GI; Phillips CL; Luxen AJ
BMC Med Phys; 2008 Nov; 8():4. PubMed ID: 18990255
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S
J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988
[TBL] [Abstract][Full Text] [Related]
13. 123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):919-27. PubMed ID: 16572305
[TBL] [Abstract][Full Text] [Related]
14. Fluorinated tracers for imaging cancer with positron emission tomography.
Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
[TBL] [Abstract][Full Text] [Related]
15. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma.
Naumann R; Beuthien-Baumann B; Reiss A; Schulze J; Hänel A; Bredow J; Kühnel G; Kropp J; Hänel M; Laniado M; Kotzerke J; Ehninger G
Br J Cancer; 2004 Feb; 90(3):620-5. PubMed ID: 14760374
[TBL] [Abstract][Full Text] [Related]
16. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.
Wyss MT; Weber B; Honer M; Späth N; Ametamey SM; Westera G; Bode B; Kaim AH; Buck A
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):312-6. PubMed ID: 14628099
[TBL] [Abstract][Full Text] [Related]
17. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
18. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Buchmann I; Vogg AT; Glatting G; Schultheiss S; Möller P; Leithäuser F; Schulte M; Gfrörer W; Kotzerke J; Reske SN
Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120
[TBL] [Abstract][Full Text] [Related]
19. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
